Pharmaceutical Resource Technology files amended quarterly report
Pharmaceutical Resource Technology, Inc. has filed an amended quarterly report, reflecting adjustments to its financial statements and commitment to compliance.
CubeSmart Reports Strong Q3 Results, Highlights Growth
CubeSmart's latest financial results show significant revenue growth, reflecting strong performance in the real estate investment trust sector.
CFO Ronald Ivan Edward Reports Stock Transactions
Ronald Ivan Edward, CFO of AleAnna, Inc., discloses stock transactions, reflecting the company's commitment to its long-term incentive plan.
INVE Technologies amends tender offer for common stock
INVE Technologies, Inc. has amended its tender offer to purchase up to $20 million in common stock, reflecting changes in financial expectations.
Valpey Financial Services reports Q3 2026 holdings update
Valpey Financial Services, LLC reveals its Q3 2026 holdings, totaling $167 million, showcasing its investment strategies in the financial services sector.
TNL Mediagene Completes Sale of Japanese Business for $5.5M
TNL Mediagene finalizes $5.5 million sale of its Japanese business to MI Company, leading to management changes and a renewed focus on Taiwan operations.
Genworth Financial announces CEO retirement, new leadership
Genworth Financial's CEO Thomas J. McInerney will retire at the end of 2026, with Jerome Upton stepping in as the new CEO and Angela Simmons as CFO.
First Phosphate Corp. Files Annual Information Form for 2026
First Phosphate Corp. has submitted its Annual Information Form, outlining its operations and mineral projects for the year ended February 28, 2026.
Lear Corporation Reports Strong Q3 Results and Outlook
Lear Corporation announces robust Q3 results with revenue and earnings growth, reflecting positive trends in the motor vehicle parts industry.
Celestica Announces Share Buyback Program Approval
Celestica Inc. has received approval for a share buyback program to repurchase up to 3.1 million shares, effective November 3, 2026.
ChoiceOne Financial Services reports strong Q3 results
ChoiceOne Financial Services announces its Q3 2026 financial results, showcasing growth in earnings and assets amid a competitive banking environment.
Flowco Holdings discloses financial statements in 8-K filing
Flowco Holdings Inc. files a current report detailing financial statements and disclosures, indicating potential shifts in financial strategy.
MEAG Munich Ergo files 13F Notice for Q3 2026
MEAG Munich Ergo has submitted a 13F Notice, outlining its investment positions as of September 30, 2026, highlighting its strategic asset management.
AutoNation Reports Third Quarter Results, Earnings Growth Continues
AutoNation, Inc. announces third-quarter results with steady earnings growth and strong cash flow, highlighting its strategic focus on share repurchases.
Sensient Technologies Reports Strong Q3 Results with 10.6% Revenue Growth
Sensient Technologies Corp announces a 10.6% revenue increase in Q3 2026, reflecting strong performance in the industrial organic chemicals sector.
INVE Technologies revises Q3 results, reports net loss
INVE Technologies, Inc. revises its Q3 financial results, reporting a preliminary net loss of $1.1 million to $1.3 million, impacting investor confidence.
Rapport Therapeutics launches $150M convertible notes offering
Rapport Therapeutics announces a $150 million public offering of convertible senior notes due 2032, aiming to strengthen its financial position.
Lingotto Investment Management acquires stake in Range Resources
Lingotto Investment Management LLP has acquired over 11.9 million shares in Range Resources Corp, marking a strategic investment in the energy sector.
TXNM Energy reports Q3 2026 financial results and outlook
TXNM Energy Inc. reveals its financial results for Q3 2026, highlighting operational performance and non-GAAP measures in the electric services sector.
Acumen Pharmaceuticals halts sabirnetug development after trial failure
Acumen Pharmaceuticals ceases development of sabirnetug after Phase 2 trial fails to meet primary endpoint, impacting its strategic direction.